The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was rejected by the Supreme Court.

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role in the opioid epidemic. The deal follows the U.S. Supreme Court’s rejection of a $6 billion agreement last year.

The Sackler family and Purdue Pharma agreed to pay $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller. Massachusetts Attorney General Andrea Campbell said that the state could receive up to $108 million of the settlement money.

Everything in my life is shaped by a company that put profits over human lives,” one woman who became addicted to OxyContin said.

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction crisis in the U.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to New York and several other states in a

Connecticut has joined a new $7.4 billion settlement agreement with OxyContin maker Purdue Pharma and the Sackler family members who own the company.

Utah will receive $57 million to combat the state’s opioid crisis if it joins the $7.4 billion settlement against the Sackler family and their former company, Purdue Pharma, the makers of OxyContin. The Utah Attorney General’s Office and Utah’s Department of Commerce Division of Consumer Protection said they expect to join the settlement in a

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and other states said.